A new review in Cancer Research Journal synthesizes evidence from cell studies, animal models, and early clinical trials showing that pulsed electromagnetic fields (PEMF) can inhibit tumor cell proliferation, induce apoptosis, and impair angiogenesis across multiple cancer types, with therapeutic responses dependent on field strength, frequency, and tumor biology.
"Increasing experimental and early clinical evidence suggests that specific electromagnetic field exposures may inhibit tumor cell proliferation, induce apoptosis, disrupt mitotic spindle formation, and impair angiogenesis across multiple cancer types."
"AM-RF EMF protocols have demonstrated early clinical activity in hepatocellular carcinoma and other malignancies without significant toxicity."
"This review examines key findings from cellular and animal studies, as well as preliminary human trials, tracing the evolution of this field from early research on alternating fields and modulated radiofrequencies to current interest in PEMF for cancer treatment."
Pulsed Electromagnetic Fields in Cancer Therapy: A Review of Experimental and Clinical Evidence
Le H (2026) Cancer Research Journal Journal Level 0โ